CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care. It specializes in developing clinically validated tests and focuses on coronary artery disease.
|HQ||Redwood City, CA, US||Map|
|Employees (est.) (Feb 2020)||60||(-9%)|
CardioDx total Funding
CardioDx latest funding size
Time since last funding
|4 years ago|
|Kleiner Perkins, DAG Ventures, Intel Capital, Duff, Ackerman and Goodrich, TPG, Mohr Davidow Ventures, Temasek Holdings, Acadia Woods Partners, Asset Management Ventures (AMV), GE Ventures, Longitude Capital, GE Capital, Reservoir Venture Partners, Artiman Ventures, Bright Capital, Alberta Investment Management, Early Stage Partners, Lifeline Ventures, Pappas Ventures, JPMorgan Partners (JPMP), Glengary Ventures, J.P. Morgan Securities Inc., JP Morgan Chase & Co.|
CardioDx has 232 Twitter Followers. The number of followers has decreased 0.3% month over month and decreased 0.4% quarter over quarter
When was CardioDx founded?
CardioDx was founded in 2004.
Who are CardioDx key executives?
CardioDx's key executives are Khush F. Mehta, Timothy Henn and David Levison.
How many employees does CardioDx have?
CardioDx has 60 employees.
Who are CardioDx competitors?
Competitors of CardioDx include Veracyte, Yourgene Health and Applied BioCode.
Where is CardioDx headquarters?
CardioDx headquarters is located at 600 Saginaw Dr, Redwood City.
Where are CardioDx offices?
CardioDx has offices in Redwood City and Greensboro.
How many offices does CardioDx have?
CardioDx has 2 offices.
Receive alerts for 300+ data fields across thousands of companies